Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT 4:00:00 PM EDT
| Market Cap (Intraday) | 410.30M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $15.61 |
| 50-Day MA | $18.06 |
| 200-Day MA | $17.19 |
Arcturus Therapeutics Holdings Inc Stock, NASDAQ:ARCT
10628 Science Center Drive, Suite 250, San Diego, California 92121
United States of America
Phone: +1.858.900.2660
Number of Employees: 177
Description
Arcturus Therapeutics Holdings, Inc. develops pharmaceuticals. It is a clinical-stage mRNA medicines and vaccines company, which focuses on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. The firm's products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.